Global Research Follow-on Biologics Market Trends and Investment F | страница 2

Drug manufacturers are now producing generic biopharmaceuticals, however, pricing remains a big concern. Increase in costs of healthcare treatment, expensive form of drugs and rise in population is likely to stimulate the market growth. However, uncertainties on outcome effect by consumption of biologics and stringent regulations is more likely to disturb the market growth during the forecast period. Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/follow-on-biologics-market/request-sample Follow-on biologics market is segmented by type comprising insulin, growth hormones, interferons, fertility hormones, fusion proteins and monoclonal antibodies. Application segment for the market comprises blood disorders, chronic and autoimmune diseases and oncology diseases. See More Reports of This Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology Market Segment: Leading players of Follow-on Biologics including: • Sandoz • Pfizer • Teva Pahrmaceutical • Celltrion • Biocon • Amgen • Samsung Biologics • Dr. Reddy's Laboratories